Global Biologics Market Report 2024

Biologics Global Market Report 2024 – By Type (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), By Drug Classification (Branded Drugs, Generic Drugs), By Route Of Administration (Oral, Other Route Of Administration), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 400 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Biologics Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Biologics Market Definition And Segments

Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses such as Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials.

The main types of biologics are monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are created in a laboratory to combat a specific infection. The various routes of administration include oral, parenteral, and others that are distributed by hospital pharmacies, retail pharmacies or drug stores, and others.

The biologics market covered in this report is segmented –

1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines

2) By Drug Classification: Branded Drugs, Generic Drugs

3) By Route Of Administration: Oral, Other Route Of Administration

4) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies or Drug Stores, Other Distribution Channels

Subsegments Covered: Anti-Cancer MAbS, Immunological MAbS, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MABS, Cardiovascular And Cerebrovascular MAbS, Other Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Other Vaccines

The biologics market size has grown strongly in recent years. It will grow from $416.65 billion in 2023 to $454.4 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to aging population, government initiatives, ability to command high prices, and increased need for immunology.

The biologics market size is expected to see rapid growth in the next few years. It will grow to $666.31 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increase in funding, technological advancements, increase in healthcare access, robust research and development activities for development of oral biologics, lean towards pills over injections, and increasing robust pipeline of biologics. Major trends in the forecast period include leveraging revised and less stringent regulations to develop new and improved biologics, shifting to biologic drug development, investing in R&D for the development of innovative biologics, and investing in research and development of biologics for the treatment of complex diseases.

Personalized Medicine Fueling Growth In The Biologics Market

The demand for personalized medicine is driving significant growth in the global biologics market. Personalized medicine, also known as precision medicine, is a medical approach that tailors healthcare and medical treatment to the individual characteristics of each patient. Personalized medicine offers the ability to customize biological treatments to a patient's specific genetic and clinical profile is transforming the healthcare landscape. For instance, according to the Personalized Medicine Coalition's report, in 2021, personalized medicines accounted for over a third of new drug approvals in 2021, representing approximately 35% of all newly approved therapeutic molecular entities. Therefore, the increasing demand for personalized medicine is driving the growth of the biologics market going forward.

Technological Advancements Driving Efficiency And Growth In The Biologics Market

Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics. Such technological advances are likely to reduce costs and expedite the development phase of biologics, allowing companies to launch their products early.

Major companies operating in the biologics market report are Merck & Co., Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Wockhardt, Zydus Cadilla, Asahi Glass Co. Ltd., China Biologic Products Holdings Inc., China Regenerative Medicine International, ABLbio, Adimmune, Henlius, Innovent Biologics, Bio-Thera, Hisun Pharma, 3SBio, Beijing ShuangLu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Biocon, Dr.Reddy’s, Mylan, Kyowa Hakko Kirin, Takeda, Mitsubishi Tanabe, AGC Biologics, Tonghua Dongbao Pharmaceutical Co., China Regenerative Medicine International, Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPharma, WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm, Lonza, Seqens, Piramal Pharma Solutions, Corden Pharma, Procos SpA and BSP Pharmaceuticals., Microgen, Geropharm, Valenta, NovaMedica, SynBi, Rani Therapeutics, Emisphere Technologies Inc., Enteris BioPharma, Allena Pharmaceuticals, Biogen Inc., Emisphere Technologies Inc., Biogen Inc., Novartis, Apotex, Gilead Sciences, Bayer, Abbott Laboratories

Effect Of Pricing And Competition In Biosimilars On The Market For Biologics

The early generation of biologics is losing its patent protection and is expected to face greater competition going forward from the entry of biosimilars into the market. Biosimilars are pharmaceuticals that are developed to have similar properties to a biological drug that has already been approved. Demand for biosimilars is being fueled by governments around the world trying to reduce healthcare costs. In India, a new biosimilar policy called the ‘Guidelines on Similar Biologics’ prepared by the Central Drugs Standard Control Organization (CSDCO) is expected to give a major boost to the Indian biosimilars industry. In the EU, a pathway for approving biosimilar medicines has existed since 2003. These less expensive alternatives increase the competitiveness of the biologics market putting downward pressure on pricing and market value growth.

Biologics Market Driven By Innovative Product

Major companies operating in the biologics industry are focused on developing innovative products, such as, oncology biosimilar to strengthen their position and gain a competitive advantage. Oncology biosimilars are a type of biologic drug that is used to treat cancer. Biosimilars are highly similar copies of existing biologic drugs. For instance, in May 2022, Biocon Biologics Limited, a subsidiary of Biocon Limited, an India-based biopharmaceutical company and Viatris Inc., a US-based pharmaceutical company, launched Abevmy, an oncology biosimilar, in Canada. Abevmy is a biosimilar medicine used for the treatment of cancer. Biosimilar medicines are biological medicines that are highly similar to other biological medicines that have already been authorized for use. They are used to treat the same conditions as the reference medicine and have the same safety and efficacy.

FDA Regulatory Revisions Foster Innovation In Biologics Manufacturing

The US Food and Drug Administration (FDA) has revised its regulations to eliminate outdated biologics requirements, thus allowing drug manufacturers to employ new manufacturing technologies and testing capabilities. Standard preparations (standard solutions containing a precisely known concentration of an element), which help to ensure the safety, purity, and potency of biologics can now be obtained from sources other than FDA’s Center for Biologics Evaluation and Research (CBER) or can be developed internally by the biologics license applicant. The FDA has also removed a rule (Section 610.21 of the FDA code) that specifies minimal potency limits to be met for certain antibodies and antigens. In addition, the FDA is also updating regulations (Section 610.53 of the FDA code) regarding storage periods and storage conditions for biologics. These amendments in regulations are expected to increase regulatory flexibility by allowing the pharmaceutical industry and the FDA to incorporate current scientific technologies in the manufacture of licensed biological products.

North America was the largest region in the biologics market in 2023. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biologics market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The biologics market consists of sales of tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The biologics market research report is one of a series of new reports from The Business Research Company that provides biologics market statistics, including biologics industry global market size, regional shares, competitors with a biologics market share, detailed biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the biologics industry. This biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Biologics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $454.4 billion
Revenue Forecast In 2033 $666.31 billion
Growth Rate CAGR of 10% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
2) By Drug Classification: Branded Drugs, Generic Drugs
3) By Route Of Administration: Oral, Other Route Of Administration
4) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels

Subsegments Covered: Anti-Cancer MAbS, Immunological MAbS, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MABS, Cardiovascular And Cerebrovascular MAbS, Other Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Other Vaccines
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Merck & Co., Inc.; AbbVie Inc.; F. Hoffmann-La Roche AG; Johnson & Johnson; Pfizer Inc.; Bristol Myers Squibb Company; Sanofi S.A.; GlaxoSmithKline Plc.; Eli Lilly and Company; Amgen Inc.; Wockhardt; Zydus Cadilla; Asahi Glass Co. Ltd.; China Biologic Products Holdings Inc.; China Regenerative Medicine International; ABLbio; Adimmune; Henlius; Innovent Biologics; Bio-Thera; Hisun Pharma; 3SBio; Beijing ShuangLu Pharmaceuticals; Qilu Pharmaceutical; Shanghai Fosun Pharmaceuticals; Biocon; Dr.Reddy’s; Mylan; Kyowa Hakko Kirin; Takeda; Mitsubishi Tanabe; AGC Biologics; Tonghua Dongbao Pharmaceutical Co.; China Regenerative Medicine International; Shanghai Fosun Pharmaceuticals; Bayer AG; Novartis AG; BiosanaPharma; WuXi; Teva UK Limited; AstraZeneca; Abbott Laboratories; Vectura Group; Fujifilm; Lonza; Seqens; Piramal Pharma Solutions; Corden Pharma; Procos SpA and BSP Pharmaceuticals.; Microgen; Geropharm; Valenta; NovaMedica; SynBi; Rani Therapeutics; Emisphere Technologies Inc.; Enteris BioPharma; Allena Pharmaceuticals; Biogen Inc.; Emisphere Technologies Inc.; Biogen Inc.; Novartis; Apotex; Gilead Sciences; Bayer; Abbott Laboratories
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Biologics Market Characteristics

    3. Biologics Product/Service Analysis -Product/Service Examples

    3.1. Biologics Supply Chain Analysis

    3.1.1. Biologics Resources

    3.1.2. Biologics Manufacturers

    3.1.3. Biologics Distributors and Retailers

    3.1.4. Biologics End Users

    3.2. Biologics Customer Information

    4. Biologics Market Trends And Strategies

    5. Biologics Market - Macro Economic Scenario

    5.1. Impact Of High Inflation On The Market

    5.2. Ukraine-Russia War Impact On The Market

    5.3. COVID-19 Impact On The Market

    6. Global Biologics Market Size and Growth

    6.1. Global Biologics Market Drivers and Restraints

    6.1.1. Drivers Of The Market

    6.1.2. Restraints Of The Market

    6.2. Global Biologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    6.3. Global Biologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    7. Biologics Market Segmentation

    7.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Monoclonal Antibodies (MAbS)

    Therapeutic Proteins

    Vaccines

    7.2. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Branded Drugs

    Generic Drugs

    7.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Parenteral

    Other Route Of Administration

    7.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    7.5. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Other Distribution Channels

    8. Biologics Market Regional And Country Analysis

    8.1. Global Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.2. Global Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. Asia-Pacific Biologics Market

    9.1. Asia-Pacific Biologics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    9.2. Asia-Pacific Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9.3. Asia-Pacific Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9.4. Asia-Pacific Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10. China Biologics Market

    10.1. China Biologics Market Overview

    10.2. China Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10.3. China Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10.4. China Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    11. India Biologics Market

    11.1. India Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.2. India Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. India Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Japan Biologics Market

    12.1. Japan Biologics Market Overview

    12.2. Japan Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Japan Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.4. Japan Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Australia Biologics Market

    13.1. Australia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Australia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Australia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. Indonesia Biologics Market

    14.1. Indonesia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.2. Indonesia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. Indonesia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. South Korea Biologics Market

    15.1. South Korea Biologics Market Overview

    15.2. South Korea Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. South Korea Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. South Korea Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. Bangladesh Biologics Market

    16.1. Bangladesh, Biologics Historic Market, 2018 - 2023, $ Billion

    16.2. Bangladesh, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    17. Thailand Biologics Market

    17.1. Thailand, Biologics Historic Market, 2018 - 2023, $ Billion

    17.2. Thailand, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    18. Vietnam Biologics Market

    18.1. Vietnam, Biologics Historic Market, 2018 - 2023, $ Billion

    18.2. Vietnam, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    19. Malaysia Biologics Market

    19.1. Malaysia, Biologics Historic Market, 2018 - 2023, $ Billion

    19.2. Malaysia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    20. Singapore Biologics Market

    20.1. Singapore, Biologics Historic Market, 2018 - 2023, $ Billion

    20.2. Singapore, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    21. Philippines Biologics Market

    21.1. Philippines, Biologics Historic Market, 2018 - 2023, $ Billion

    21.2. Philippines, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    22. Hong kong Biologics Market

    22.1. Hong Kong, Biologics Historic Market, 2018 - 2023, $ Billion

    22.2. Hong Kong, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    23. New Zealand Biologics Market

    23.1. New Zealand, Biologics Historic Market, 2018 - 2023, $ Billion

    23.2. New Zealand, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    24. Western Europe Biologics Market

    24.1. Western Europe Biologics Market Overview

    24.2. Western Europe Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. Western Europe Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. Western Europe Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. UK Biologics Market

    25.1. UK Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.2. UK Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. UK Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. Germany Biologics Market

    26.1. Germany Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.2. Germany Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. Germany Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. France Biologics Market

    27.1. France Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. France Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. France Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Italy Biologics Market

    28.1. Italy Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.2. Italy Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Italy Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Spain Biologics Market

    29.1. Spain Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.2. Spain Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Spain Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Austria Biologics Market

    30.1. Austria, Biologics Historic Market, 2018 - 2023, $ Billion

    30.2. Austria, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    31. Belgium Biologics Market

    31.1. Belgium, Biologics Historic Market, 2018 - 2023, $ Billion

    31.2. Belgium, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    32. Denmark Biologics Market

    32.1. Denmark, Biologics Historic Market, 2018 - 2023, $ Billion

    32.2. Denmark, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    33. Finland Biologics Market

    33.1. Finland, Biologics Historic Market, 2018 - 2023, $ Billion

    33.2. Finland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    34. Ireland Biologics Market

    34.1. Ireland, Biologics Historic Market, 2018 - 2023, $ Billion

    34.2. Ireland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    35. Netherlands Biologics Market

    35.1. Netherlands, Biologics Historic Market, 2018 - 2023, $ Billion

    35.2. Netherlands, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    36. Norway Biologics Market

    36.1. Norway, Biologics Historic Market, 2018 - 2023, $ Billion

    36.2. Norway, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    37. Portugal Biologics Market

    37.1. Portugal, Biologics Historic Market, 2018 - 2023, $ Billion

    37.2. Portugal, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    38. Sweden Biologics Market

    38.1. Sweden, Biologics Historic Market, 2018 - 2023, $ Billion

    38.2. Sweden, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    39. Switzerland Biologics Market

    39.1. Switzerland, Biologics Historic Market, 2018 - 2023, $ Billion

    39.2. Switzerland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    40. Eastern Europe Biologics Market

    40.1. Eastern Europe Biologics Market Overview

    40.2. Eastern Europe Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    40.3. Eastern Europe Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    40.4. Eastern Europe Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    41. Russia Biologics Market

    41.1. Russia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    41.2. Russia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    41.3. Russia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    42. Czech Republic Biologics Market

    42.1. Czech Republic, Biologics Historic Market, 2018 - 2023, $ Billion

    42.2. Czech Republic, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    43. Poland Biologics Market

    43.1. Poland, Biologics Historic Market, 2018 - 2023, $ Billion

    43.2. Poland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    44. Romania Biologics Market

    44.1. Romania, Biologics Historic Market, 2018 - 2023, $ Billion

    44.2. Romania, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    45. Ukraine Biologics Market

    45.1. Ukraine, Biologics Historic Market, 2018 - 2023, $ Billion

    45.2. Ukraine, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    46. North America Biologics Market

    46.1. North America Biologics Market Overview

    46.2. North America Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    46.3. North America Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    46.4. North America Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    47. USA Biologics Market

    47.1. USA Biologics Market Overview

    47.2. USA Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    47.3. USA Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    47.4. USA Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    48. Canada Biologics Market

    48.1. Canada Biologics Market Overview

    48.2. Canada Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    48.3. Canada Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    48.4. Canada Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    49. Mexico Biologics Market

    49.1. Mexico, Biologics Historic Market, 2018 - 2023, $ Billion

    49.2. Mexico, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    50. South America Biologics Market

    50.1. South America Biologics Market Overview

    50.2. South America Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    50.3. South America Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    50.4. South America Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    51. Brazil Biologics Market

    51.1. Brazil Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    51.2. Brazil Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    51.3. Brazil Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    52. Chile Biologics Market

    52.1. Chile, Biologics Historic Market, 2018 - 2023, $ Billion

    52.2. Chile, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    53. Argentina Biologics Market

    53.1. Argentina, Biologics Historic Market, 2018 - 2023, $ Billion

    53.2. Argentina, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    54. Colombia Biologics Market

    54.1. Colombia, Biologics Historic Market, 2018 - 2023, $ Billion

    54.2. Colombia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    55. Peru Biologics Market

    55.1. Peru, Biologics Historic Market, 2018 - 2023, $ Billion

    55.2. Peru, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    56. Middle East Biologics Market

    56.1. Middle East Biologics Market Overview

    56.2. Middle East Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    56.3. Middle East Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    56.4. Middle East Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    57. Saudi Arabia Biologics Market

    57.1. Saudi Arabia, Biologics Historic Market, 2018 - 2023, $ Billion

    57.2. Saudi Arabia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    58. Israel Biologics Market

    58.1. Israel, Biologics Historic Market, 2018 - 2023, $ Billion

    58.2. Israel, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    59. Iran Biologics Market

    59.1. Iran, Biologics Historic Market, 2018 - 2023, $ Billion

    59.2. Iran, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    60. Turkey Biologics Market

    60.1. Turkey, Biologics Historic Market, 2018 - 2023, $ Billion

    60.2. Turkey, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    61. United Arab Emirates Biologics Market

    61.1. United Arab Emirates, Biologics Historic Market, 2018 - 2023, $ Billion

    61.2. United Arab Emirates, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    62. Africa Biologics Market

    62.1. Africa Biologics Market Overview

    62.2. Africa Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    62.3. Africa Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    62.4. Africa Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    63. Egypt Biologics Market

    63.1. Egypt, Biologics Historic Market, 2018 - 2023, $ Billion

    63.2. Egypt, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    64. Nigeria Biologics Market

    64.1. Nigeria, Biologics Historic Market, 2018 - 2023, $ Billion

    64.2. Nigeria, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    65. South Africa Biologics Market

    65.1. South Africa, Biologics Historic Market, 2018 - 2023, $ Billion

    65.2. South Africa, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

    66. Biologics Market Competitive Landscape And Company Profiles

    66.1. Biologics Market Competitive Landscape

    66.2. Biologics Market Company Profiles

    66.2.1. Merck & Co., Inc.

    66.2.1.1. Overview

    66.2.1.2. Products and Services

    66.2.1.3. Strategy

    66.2.1.4. Financial Performance

    66.2.2. AbbVie Inc.

    66.2.2.1. Overview

    66.2.2.2. Products and Services

    66.2.2.3. Strategy

    66.2.2.4. Financial Performance

    66.2.3. F. Hoffmann-La Roche AG

    66.2.3.1. Overview

    66.2.3.2. Products and Services

    66.2.3.3. Strategy

    66.2.3.4. Financial Performance

    66.2.4. Johnson & Johnson

    66.2.4.1. Overview

    66.2.4.2. Products and Services

    66.2.4.3. Strategy

    66.2.4.4. Financial Performance

    66.2.5. Pfizer Inc.

    66.2.5.1. Overview

    66.2.5.2. Products and Services

    66.2.5.3. Strategy

    66.2.5.4. Financial Performance

    67. Biologics Market Other Major And Innovative Companies

    67.1. Bristol Myers Squibb Company

    67.2. Sanofi S.A.

    67.3. GlaxoSmithKline Plc.

    67.4. Eli Lilly and Company

    67.5. Amgen Inc.

    67.6. Wockhardt

    67.7. Zydus Cadilla

    67.8. Asahi Glass Co. Ltd.

    67.9. China Biologic Products Holdings Inc.

    67.10. China Regenerative Medicine International

    67.11. ABLbio

    67.12. Adimmune

    67.13. Henlius

    67.14. Innovent Biologics

    67.15. Bio-Thera

    68. Global Biologics Market Competitive Benchmarking

    69. Global Biologics Market Competitive Dashboard

    70. Key Mergers And Acquisitions In The Biologics Market

    71. Biologics Market Future Outlook and Potential Analysis

    71.1 Biologics Market In 2028 - Countries Offering Most New Opportunities

    71.2 Biologics Market In 2028 - Segments Offering Most New Opportunities

    71.3 Biologics Market In 2028 - Growth Strategies

    71.3.1 Market Trend Based Strategies

    71.3.2 Competitor Strategies

    72. Appendix

    72.1. Abbreviations

    72.2. Currencies

    72.3. Historic And Forecast Inflation Rates

    72.4. Research Inquiries

    72.5. The Business Research Company

    72.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Bangladesh Historic Market Growth, 2018-2023, $ Billion
  • Table 32: Bangladesh Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 33: Thailand Historic Market Growth, 2018-2023, $ Billion
  • Table 34: Thailand Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 35: Vietnam Historic Market Growth, 2018-2023, $ Billion
  • Table 36: Vietnam Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 37: Malaysia Historic Market Growth, 2018-2023, $ Billion
  • Table 38: Malaysia Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 39: Singapore Historic Market Growth, 2018-2023, $ Billion
  • Table 40: Singapore Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 41: Philippines Historic Market Growth, 2018-2023, $ Billion
  • Table 42: Philippines Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 43: Hong Kong Historic Market Growth, 2018-2023, $ Billion
  • Table 44: Hong Kong Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 45: New Zealand Historic Market Growth, 2018-2023, $ Billion
  • Table 46: New Zealand Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 47: Western Europe, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Western Europe, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Western Europe, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: UK, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: UK, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: UK, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Germany, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Germany, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: Germany, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: France, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: France, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: France, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Italy, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Italy, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Italy, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Spain, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Spain, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: Spain, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Austria Historic Market Growth, 2018-2023, $ Billion
  • Table 66: Austria Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 67: Belgium Historic Market Growth, 2018-2023, $ Billion
  • Table 68: Belgium Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 69: Denmark Historic Market Growth, 2018-2023, $ Billion
  • Table 70: Denmark Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 71: Finland Historic Market Growth, 2018-2023, $ Billion
  • Table 72: Finland Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 73: Ireland Historic Market Growth, 2018-2023, $ Billion
  • Table 74: Ireland Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 75: Netherlands Historic Market Growth, 2018-2023, $ Billion
  • Table 76: Netherlands Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 77: Norway Historic Market Growth, 2018-2023, $ Billion
  • Table 78: Norway Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 79: Portugal Historic Market Growth, 2018-2023, $ Billion
  • Table 80: Portugal Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 81: Sweden Historic Market Growth, 2018-2023, $ Billion
  • Table 82: Sweden Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 83: Switzerland Historic Market Growth, 2018-2023, $ Billion
  • Table 84: Switzerland Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 85: Eastern Europe, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 86: Eastern Europe, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 87: Eastern Europe, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 88: Russia, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 89: Russia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 90: Russia, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 91: Czech Republic Historic Market Growth, 2018-2023, $ Billion
  • Table 92: Czech Republic Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 93: Poland Historic Market Growth, 2018-2023, $ Billion
  • Table 94: Poland Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 95: Romania Historic Market Growth, 2018-2023, $ Billion
  • Table 96: Romania Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 97: Ukraine Historic Market Growth, 2018-2023, $ Billion
  • Table 98: Ukraine Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 99: North America, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 100: North America, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 101: North America, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 102: USA, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 103: USA, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 104: USA, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 105: Canada, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 106: Canada, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 107: Canada, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 108: Mexico Historic Market Growth, 2018-2023, $ Billion
  • Table 109: Mexico Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 110: South America, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 111: South America, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 112: South America, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 113: Brazil, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 114: Brazil, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 115: Brazil, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 116: Chile Historic Market Growth, 2018-2023, $ Billion
  • Table 117: Chile Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 118: Argentina Historic Market Growth, 2018-2023, $ Billion
  • Table 119: Argentina Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 120: Colombia Historic Market Growth, 2018-2023, $ Billion
  • Table 121: Colombia Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 122: Peru Historic Market Growth, 2018-2023, $ Billion
  • Table 123: Peru Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 124: Middle East, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 125: Middle East, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 126: Middle East, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 127: Saudi Arabia Historic Market Growth, 2018-2023, $ Billion
  • Table 128: Saudi Arabia Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 129: Israel Historic Market Growth, 2018-2023, $ Billion
  • Table 130: Israel Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 131: Iran Historic Market Growth, 2018-2023, $ Billion
  • Table 132: Iran Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 133: Turkey Historic Market Growth, 2018-2023, $ Billion
  • Table 134: Turkey Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 135: United Arab Emirates Historic Market Growth, 2018-2023, $ Billion
  • Table 136: United Arab Emirates Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 137: Africa, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 138: Africa, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 139: Africa, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 140: Egypt Historic Market Growth, 2018-2023, $ Billion
  • Table 141: Egypt Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 142: Nigeria Historic Market Growth, 2018-2023, $ Billion
  • Table 143: Nigeria Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 144: South Africa Historic Market Growth, 2018-2023, $ Billion
  • Table 145: South Africa Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 146: Merck & Co., Inc. Financial Performance
  • Table 147: AbbVie Inc. Financial Performance
  • Table 148: F. Hoffmann-La Roche AG Financial Performance
  • Table 149: Johnson & Johnson Financial Performance
  • Table 150: Pfizer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Bangladesh Historic Market Growth, 2018-2023, $ Billion
  • Figure 32: Bangladesh Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 33: Thailand Historic Market Growth, 2018-2023, $ Billion
  • Figure 34: Thailand Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 35: Vietnam Historic Market Growth, 2018-2023, $ Billion
  • Figure 36: Vietnam Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 37: Malaysia Historic Market Growth, 2018-2023, $ Billion
  • Figure 38: Malaysia Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 39: Singapore Historic Market Growth, 2018-2023, $ Billion
  • Figure 40: Singapore Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 41: Philippines Historic Market Growth, 2018-2023, $ Billion
  • Figure 42: Philippines Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 43: Hong Kong Historic Market Growth, 2018-2023, $ Billion
  • Figure 44: Hong Kong Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 45: New Zealand Historic Market Growth, 2018-2023, $ Billion
  • Figure 46: New Zealand Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 47: Western Europe, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Western Europe, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Western Europe, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: UK, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: UK, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: UK, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Germany, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Germany, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: Germany, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: France, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: France, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: France, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Italy, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Italy, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Italy, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Spain, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Spain, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: Spain, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Austria Historic Market Growth, 2018-2023, $ Billion
  • Figure 66: Austria Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 67: Belgium Historic Market Growth, 2018-2023, $ Billion
  • Figure 68: Belgium Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 69: Denmark Historic Market Growth, 2018-2023, $ Billion
  • Figure 70: Denmark Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 71: Finland Historic Market Growth, 2018-2023, $ Billion
  • Figure 72: Finland Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 73: Ireland Historic Market Growth, 2018-2023, $ Billion
  • Figure 74: Ireland Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 75: Netherlands Historic Market Growth, 2018-2023, $ Billion
  • Figure 76: Netherlands Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 77: Norway Historic Market Growth, 2018-2023, $ Billion
  • Figure 78: Norway Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 79: Portugal Historic Market Growth, 2018-2023, $ Billion
  • Figure 80: Portugal Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 81: Sweden Historic Market Growth, 2018-2023, $ Billion
  • Figure 82: Sweden Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 83: Switzerland Historic Market Growth, 2018-2023, $ Billion
  • Figure 84: Switzerland Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 85: Eastern Europe, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 86: Eastern Europe, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 87: Eastern Europe, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 88: Russia, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 89: Russia, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 90: Russia, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 91: Czech Republic Historic Market Growth, 2018-2023, $ Billion
  • Figure 92: Czech Republic Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 93: Poland Historic Market Growth, 2018-2023, $ Billion
  • Figure 94: Poland Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 95: Romania Historic Market Growth, 2018-2023, $ Billion
  • Figure 96: Romania Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 97: Ukraine Historic Market Growth, 2018-2023, $ Billion
  • Figure 98: Ukraine Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 99: North America, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 100: North America, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 101: North America, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 102: USA, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 103: USA, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 104: USA, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 105: Canada, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 106: Canada, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 107: Canada, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 108: Mexico Historic Market Growth, 2018-2023, $ Billion
  • Figure 109: Mexico Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 110: South America, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 111: South America, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 112: South America, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 113: Brazil, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 114: Brazil, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 115: Brazil, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 116: Chile Historic Market Growth, 2018-2023, $ Billion
  • Figure 117: Chile Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 118: Argentina Historic Market Growth, 2018-2023, $ Billion
  • Figure 119: Argentina Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 120: Colombia Historic Market Growth, 2018-2023, $ Billion
  • Figure 121: Colombia Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 122: Peru Historic Market Growth, 2018-2023, $ Billion
  • Figure 123: Peru Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 124: Middle East, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 125: Middle East, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 126: Middle East, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 127: Saudi Arabia Historic Market Growth, 2018-2023, $ Billion
  • Figure 128: Saudi Arabia Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 129: Israel Historic Market Growth, 2018-2023, $ Billion
  • Figure 130: Israel Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 131: Iran Historic Market Growth, 2018-2023, $ Billion
  • Figure 132: Iran Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 133: Turkey Historic Market Growth, 2018-2023, $ Billion
  • Figure 134: Turkey Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 135: United Arab Emirates Historic Market Growth, 2018-2023, $ Billion
  • Figure 136: United Arab Emirates Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 137: Africa, Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 138: Africa, Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 139: Africa, Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 140: Egypt Historic Market Growth, 2018-2023, $ Billion
  • Figure 141: Egypt Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 142: Nigeria Historic Market Growth, 2018-2023, $ Billion
  • Figure 143: Nigeria Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 144: South Africa Historic Market Growth, 2018-2023, $ Billion
  • Figure 145: South Africa Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 146: Merck & Co., Inc. Financial Performance
  • Figure 147: AbbVie Inc. Financial Performance
  • Figure 148: F. Hoffmann-La Roche AG Financial Performance
  • Figure 149: Johnson & Johnson Financial Performance
  • Figure 150: Pfizer Inc. Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Orthobiologics Devices And Equipment Global Market Report 2024 – By Product Type (Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics), By Application (Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery), By End Use (Hospitals, Orthopedic Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Oral Biologics & Biosimilar Drugs Global Market Report 2024 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Agricultural Biologics Global Market Report 2024 – By Type (Biopesticides, Biofertilizers, Biostimulants), By Source (Microbials, Macrobials, Biochemicals, Other Sources), By Mode of Application (Foliar Spray, Soil Treatment, Seed Treatment, Post-Harvest), By Application (Cereals And Grains, Oilseed And Pulses, Fruits And Vegetables, Turf And Ornamentals, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Oral Biologics & Biosimilars Global Market Report 2024 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors, Immunostimulants, GPCR Modulators, Other Therapies), By Disease (Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases), By Molecule Type (Vaccines, Proteins and Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Therapeutic Proteins Global Market Report 2024 – By Product Type (Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics), By Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Bi-Specific MAbS Global Market Report 2024 – By Type (Catumaxomab (Removab), Blinatumomab, Duligotumab, Emicizumab, Amivantamab, Faricimab, Teclistamab), By Product Type (In Vivo, In Vitro), By Indication (Cancer, Hemophilia A, Ophthalmic), By End Use (Hospitals, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Frequently Asked Questions

What is the definition of the biologics market?

Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses such Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials. For further insights on the biologics market, request a sample here

How will the biologics market drivers and restraints affect the biologics market dynamics? What forces will shape the biologics industry going forward?

The biologics market growth is aided by technological developments. However, some biologics market restraints include introduction of less expensive alternatives which increase the competitiveness of the biologics. For further insights on the biologics market, request a sample here

What is the forecast market size or the forecast market value of the biologics market?

The biologics market is expected to reach $599.62 billion in 2027 at a rate of 9.5%. For further insights on the biologics market, request a sample here

How is the biologics market segmented?

The global biologics market is segmented as
1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribtuion Channels
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
Subegments Covered: Anti-Cancer MAbS, Immunological MAbS, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MABS, Cardiovascular And Cerebrovascular MAbS, Other Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Other Vaccines
For further insights on the biologics market, request a sample here

Which region has the largest share of the biologics market? What are the largest region's market size and growth rate?

North America was the largest region in the biologics market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here request a sample here.

Who are the major players in the biologics market?

Key competitors in the biologics market are, AbbVie, Johnson & Johnson, Amgen, Sanofi S.A, F. Hoffmann-La Roche Ltd., GlaxosmithKline, Novartis AG, Pfizer Inc., Teva Pharmaceuticals, CSL. For further insights on the biologics market, request a sample here.

What are the key trends in the biologics market?

For further insights on the biologics, request a sample here.

What are the major opportunities in the biologics market? What are the strategies for the biologics market?

For detailed insights on the major opportunities and strategies in the biologics market, request a sample here.

How does the biologics market relate to the overall economy and other similar markets?

For detailed insights on biologics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the biologics industry?

For detailed insights on the mergers and acquisitions in the biologics industry, request a sample here.

What are the key dynamics influencing the biologics market growth? SWOT analysis of the biologics market.

For detailed insights on the key dynamics influencing the biologics market growth and SWOT analysis of the biologics industry, request a sample here.